Sandimmun Neoral 25 mg soft capsules
Spain
Table of Contents
Patient Information Leaflet
Introduction
Patient Information Leaflet
Sandimmun Neoral 25 mg Soft Capsules
ciclosporin
Read all of this leaflet carefully before you start taking this medicine, as it contains important information for you.
- Keep this leaflet, as you may need to read it again.
- If you have any questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you only. Do not pass it on to others, even if they have the same symptoms as you, because it may harm them.
- If you experience any side effects, talk to your doctor or pharmacist, even if the side effects are not listed in this leaflet. See section 4.
Contents of this leaflet:
- What Sandimmun Neoral is and what it is used for
- What you need to know before taking Sandimmun Neoral
- How to take Sandimmun Neoral
- Possible side effects
- How to store Sandimmun Neoral
- Contents of the pack and other information
1. What Sandimmun Neoral is and what it is used for
What Sandimmun Neoral is
The name of your medicine is Sandimmun Neoral. It contains the active substance ciclosporin. It belongs to a group of medicines known as immunosuppressants. These medicines are used to reduce immune responses in the body.
What Sandimmun Neoral is used for and how it works
- If you have undergone an organ, bone marrow or stem cell transplant, the function of Sandimmun Neoral is to control your body's immune system. Sandimmun Neoral prevents rejection of transplanted organs by suppressing the development of certain cells that would normally attack the transplanted tissue.
- If you have an autoimmune disease, in which your body's immune response attacks its own cells, Sandimmun Neoral suppresses this immune reaction. These diseases include eye disorders that may affect your vision (endogenous uveitis, including Behçet's uveitis), severe cases of certain skin diseases (atopic dermatitis, or eczema, and psoriasis), severe rheumatoid arthritis, and a kidney disease called nephrotic syndrome.
2. What you need to know before starting to take Sandimmun Neoral
If you are taking Sandimmun Neoral after a transplant, it must only have been prescribed by a doctor experienced in transplantation and/or autoimmune diseases.
The recommendations in this leaflet may vary depending on whether you are taking the medicine for a transplant or for an autoimmune disease.
Follow all instructions from your doctor carefully. They may differ from the general information contained in this leaflet.
Do not take Sandimmun Neoral:
- if you are allergic to cyclosporine or any of the other ingredients of this medicine (listed in section 6).
- with medicines containing Hypericum perforatum (St. John’s wort).
- with medicines containing dabigatran etexilate (used to prevent blood clots after surgery), bosentan, or aliskiren (used to lower high blood pressure).
If any of these apply to you, do not take Sandimmun Neoral and inform your doctor. If you are unsure, consult your doctor before taking Sandimmun Neoral.
Warnings and precautions
Before and during treatment with Sandimmun Neoral, inform your doctor immediately:
- if you have any signs of infection, such as fever or sore throat. Sandimmun Neoral suppresses the immune system and may also affect your body’s ability to fight infections.
- if you have liver problems.
- if you have kidney problems. Your doctor will perform regular blood tests and may adjust your dose if necessary.
- if you have high blood pressure. Your doctor will monitor your blood pressure regularly and may prescribe medication to lower it if needed.
- if you have low magnesium levels in your body. Your doctor may administer magnesium supplements, especially shortly after surgery if you have undergone a transplant.
- if you have high potassium levels in your blood.
- if you suffer from gout.
- if you need to receive a vaccine.
If you experience any of the above conditions before or during treatment with Sandimmun Neoral, inform your doctor immediately.
Sun protection and sunlight exposure
Sandimmun Neoral suppresses your immune system. This may increase the risk of developing cancer, primarily of the skin and lymphatic system. Therefore, you should limit your exposure to sunlight and UV rays by:
- wearing appropriate protective clothing.
- frequently applying a high-protection sunscreen.
Consult your doctor before taking Sandimmun Neoral:
- if you have or have had alcohol-related problems.
- if you suffer from epilepsy.
- if you have any liver problems.
- if you are pregnant.
- if you are breastfeeding.
- if this medicine is prescribed for a child.
If any of these situations apply to you (or you are unsure), inform your doctor before taking Sandimmun Neoral. This is because this medicine contains alcohol (see section “Sandimmun Neoral contains ethanol” below).
Monitoring during your treatment with Sandimmun Neoral
Your doctor will monitor:
- cyclosporine blood levels, especially if you have undergone a transplant,
- your blood pressure before starting treatment and regularly during treatment,
- how well your liver and kidneys are functioning,
- your blood lipid levels (fats).
If you have any questions about how Sandimmun Neoral works or why it has been prescribed to you, consult your doctor.
Additionally, if you are taking Sandimmun Neoral for a condition other than transplantation (intermediate or posterior uveitis and Behçet's uveitis, atopic dermatitis, severe rheumatoid arthritis, or nephrotic syndrome), do not take Sandimmun Neoral:
- if you have kidney problems (except for nephrotic syndrome).
- if you have an infection that is not controlled with medication.
- if you have any type of cancer.
- if you have uncontrolled high blood pressure (hypertension) not managed with medication. If you develop high blood pressure during treatment that cannot be controlled, your doctor should discontinue treatment with Sandimmun Neoral.
If any of these situations apply to you, do not take Sandimmun Neoral. If you are unsure, consult your doctor or pharmacist before taking Sandimmun Neoral.
If you are being treated for Behçet's uveitis, your doctor will monitor you carefully, especially if you experience neurological symptoms (e.g.: frequent forgetfulness, personality changes over time, psychiatric or mood disorders, burning sensation in the limbs, reduced sensitivity in the limbs, tingling in the limbs, limb weakness, motor disturbances, headache with or without nausea and vomiting, visual disturbances including limited eye movement).
Your doctor will monitor you closely if you are elderly and being treated for psoriasis or atopic dermatitis. If Sandimmun Neoral has been prescribed to treat your psoriasis or atopic dermatitis, you must not be exposed to UVB radiation or photochemotherapy during treatment.
Children and adolescents
Sandimmun Neoral should not be administered to children for indications other than transplantation, except for the treatment of nephrotic syndrome.
Elderly population (65 years of age and older)
There is limited experience with Sandimmun Neoral in elderly patients. Your doctor must monitor your kidney function. If you are over 65 years old and have psoriasis or atopic dermatitis, Sandimmun Neoral should only be used if your condition is particularly severe.
Other medicines and Sandimmun Neoral
Inform your doctor or pharmacist if you are taking, have recently taken, or might need to take any other medicines.
In particular, inform your doctor or pharmacist if you are taking any of the following medicines before or during treatment with Sandimmun Neoral:
-
Medicines that may affect your potassium levels. These include medicines containing potassium, potassium supplements, potassium-sparing diuretics, and certain medicines that lower blood pressure.
-
Methotrexate. Used to treat tumors, severe psoriasis, and severe rheumatoid arthritis.
-
Medicines that may increase or decrease cyclosporine levels (the active substance in Sandimmun Neoral) in your blood. Your doctor may check your cyclosporine blood level when starting or stopping other medicines.
-
Medicines that may increase cyclosporine levels in your blood include: antibiotics (such as erythromycin or azithromycin), antifungals (voriconazole, itraconazole), medicines used for heart disorders or high blood pressure (diltiazem, nicardipine, verapamil, amiodarone), metoclopramide (used to stop vomiting), oral contraceptives, danazol (used to treat menstrual disorders), medicines used to treat gout (allopurinol), cholic acid and derivatives (used to treat gallstones), protease inhibitors used to treat HIV, imatinib (used to treat leukemia or tumors), colchicine, telaprevir (used to treat hepatitis C), cannabidiol (used, among other things, to treat epileptic seizures).
-
Medicines that may decrease cyclosporine levels in your blood include: barbiturates (used to help you sleep), certain anticonvulsants (such as carbamazepine or phenytoin), octreotide (used to treat acromegaly or neuroendocrine tumors in the intestine), antibacterial medicines used to treat tuberculosis, orlistat (used to help lose weight), herbal medicines containing St. John’s wort, ticlopidine (used after stroke), certain medicines that lower blood pressure (bosentan), and terbinafine (an antifungal medicine used to treat toe and nail infections).
-
Medicines that may affect your kidneys. These include: antibacterial medicines (gentamicin, tobramycin, ciprofloxacin), antifungal medicines containing amphotericin B, medicines used for urinary tract infections containing trimethoprim, cancer medicines containing melphalan, medicines used to reduce stomach acid (acid secretion inhibitors of the H2-receptor antagonist type), tacrolimus, analgesics (non-steroidal anti-inflammatory drugs such as diclofenac), fibric acid medicines (used to reduce blood fat levels).
-
Nifedipine. Used to treat high blood pressure and chest pain. You may develop swollen gums that could grow over your teeth if you are taking nifedipine during cyclosporine treatment.
-
Digoxin (used to treat heart disorders), cholesterol-lowering medicines (HMG-CoA reductase inhibitors also known as statins), prednisolone, etoposide (used to treat cancer), repaglinide (an oral antidiabetic medicine), immunosuppressants (everolimus, sirolimus), ambrisentan, and specific anticancer medicines called anthracyclines (such as doxorubicin).
-
Sodium mycophenolate or mycophenolate mofetil (an immunosuppressant) and eltrombopag (used to treat bleeding disorders).
If any of these situations apply to you (or you are unsure), inform your doctor or pharmacist before taking Sandimmun Neoral.
Taking Sandimmun Neoral with food and drinks
Do not take Sandimmun Neoral with grapefruit or grapefruit juice. This is because it may affect how Sandimmun Neoral works.
Pregnancy and breastfeeding
Consult your doctor or pharmacist before taking this medicine.
- Inform your doctor if you are pregnant or intend to become pregnant. Experience with Sandimmun Neoral in pregnant women is limited. In general, Sandimmun Neoral should not be administered during pregnancy. If it is necessary for you to take this medicine, your doctor will discuss the potential benefits and risks of taking it during pregnancy.
- Inform your doctor if you are breastfeeding. Breastfeeding is not recommended during treatment with Sandimmun Neoral. This is because cyclosporine, the active substance, passes into breast milk and could affect your baby.
Hepatitis C
Inform your doctor if you have hepatitis C. Your liver function may change with hepatitis C treatment, which may affect cyclosporine blood levels. Your doctor may need to closely monitor cyclosporine blood levels and adjust the dose after starting hepatitis C treatment.
Driving and using machines
You may feel drowsy, disoriented, or experience blurred vision after taking Sandimmun Neoral. Be cautious when driving or operating machinery while taking Sandimmun Neoral until you know how it affects you.
Sandimmun Neoral contains ethanol
Sandimmun Neoral contains 25 mg of alcohol (ethanol) per 25 mg capsule of Sandimmun Neoral, corresponding to 11.8% v/v. A 500 mg dose of Sandimmun Neoral contains 500 mg of ethanol, equivalent to approximately 13 ml of beer or 5 ml of wine. The small amount of alcohol in this medicine will have no noticeable effect.
Sandimmun Neoral contains castor oil
Sandimmun Neoral may cause stomach discomfort and diarrhea because it contains castor oil.
Sandimmun Neoral contains propylene glycol
This medicine contains 46.42 mg of propylene glycol in each 25 mg capsule.
If the baby is less than 4 weeks old, consult your doctor or pharmacist, particularly if the baby has been given other medicines containing propylene glycol or alcohol.
Sandimmun Neoral contains sodium
This medicine contains less than 23 mg of sodium (1 mmol) per 25 mg capsule; this is essentially “sodium-free”.
3. How to take Sandimmun Neoral
Follow exactly the instructions for administering this medicine as given by your doctor. If in doubt, consult your doctor again.
Do not take more than the recommended dose.
Your doctor will carefully adjust the dose of this medicine to your individual needs. Taking too much of this medicine may affect your kidneys. You will have regular blood tests and hospital visits, especially after transplantation. This will allow you to discuss your treatment and any problems you may have with your doctor.
How much Sandimmun Neoral should you take?
Your doctor will tell you the correct dose of Sandimmun Neoral for you. This depends on your body weight and the reason for which you are taking this medicine. Your doctor will also inform you how often you should take your medicine.
- In adults:
Organ, bone marrow, and stem cell transplantation
- The total daily dose is normally between 2 mg and 15 mg per kilogram of body weight. This is divided into two doses.
- Higher doses are usually used before and immediately after your transplant. Lower doses are used once your transplanted organ or bone marrow has stabilized.
- Your doctor will adjust the dose to one that is ideal for you. For this purpose, your doctor may need to perform some blood tests.
Endogenous uveitis
- The total daily dose is normally between 5 mg and 7 mg per kilogram of body weight. This is divided into two doses.
Nephrotic syndrome
- The total daily dose for adults is normally 5 mg per kilogram of body weight. This is divided into two doses. In patients with renal impairment, the initial daily dose should not exceed 2.5 mg per kilogram of body weight.
Severe rheumatoid arthritis
- The total daily dose is normally between 3 mg and 5 mg per kilogram of body weight. This is divided into two doses.
Psoriasis and atopic dermatitis
-
The total daily dose is normally between 2.5 mg and 5 mg per kilogram of body weight. This is divided into two doses.
-
In children:
Nephrotic syndrome
- The total daily dose for children is normally 6 mg per kilogram of body weight. This is divided into two doses. In patients with renal impairment, the initial daily dose should not exceed 2.5 mg per kilogram of body weight.
Follow your doctor's instructions exactly and never change the dose yourself, even if you feel well.
Switching from Sandimmun to Sandimmun Neoral
You may have previously been taking another medicine called Sandimmun soft gelatin capsules or Sandimmun oral solution. Your doctor may decide to switch you to Sandimmun Neoral oral solution.
- All these medicines contain ciclosporin as the active substance.
- Sandimmun Neoral is a different and improved formulation of ciclosporin compared to Sandimmun. Ciclosporin is better absorbed into the blood with Sandimmun Neoral and is less likely to be affected by food intake. This means that ciclosporin blood levels remain more consistent with Sandimmun Neoral than with Sandimmun.
If your doctor switches you from Sandimmun to Sandimmun Neoral:
- Do not take Sandimmun again unless your doctor tells you to.
- After switching from Sandimmun to Sandimmun Neoral, your doctor will monitor you more closely for a short period of time. This is due to the change in how ciclosporin is absorbed into the blood. Your doctor will ensure you are taking the correct dose according to your individual needs.
- You may experience some adverse effects. If this happens, inform your doctor or pharmacist. It may be necessary to reduce your dose. Never reduce your dose yourself unless instructed by a doctor.
If your doctor switches you from one oral ciclosporin formulation to another
After switching from one oral ciclosporin formulation to another:
- Your doctor will monitor you more closely for a short period of time.
- You may experience some adverse effects. If this happens, inform your doctor or pharmacist. It may be necessary to adjust your dose. Never adjust your dose yourself unless instructed by a doctor.
When to take Sandimmun Neoral
Take Sandimmun Neoral at the same time each day. This is very important if you have undergone a transplant.
How to take Sandimmun Neoral
Your daily dose must always be administered as two doses.
Remove the capsules from the blister pack. Swallow the capsules whole with a glass of water.
How long to take Sandimmun Neoral
Your doctor will tell you how long you need to take Sandimmun Neoral. This depends on whether you are taking it after a transplant or for the treatment of severe skin diseases, rheumatoid arthritis, uveitis, or nephrotic syndrome. In the case of severe skin rash, treatment usually lasts 8 weeks.
Continue taking Sandimmun Neoral for as long as your doctor tells you to.
If you have any doubts about how long you should take Sandimmun Neoral, consult your doctor or pharmacist.
If you take more Sandimmun Neoral than you should
If you accidentally take an excessive dose of the medicine, inform your doctor immediately or go to the nearest hospital emergency department. You may require medical attention.
You can also call the Toxicology Information Service at telephone number 91 562 04 20, stating the medicine and the amount taken.
If you forget to take Sandimmun Neoral
- If you forget to take a dose, take it as soon as you remember. However, if it is nearly time for your next dose, skip the missed dose. Then continue as before.
- Do not take a double dose to make up for forgotten doses.
If you stop taking Sandimmun Neoral
Do not stop taking Sandimmun Neoral unless your doctor tells you to.
Continue taking Sandimmun Neoral even if you feel well. Stopping treatment with Sandimmun Neoral may increase the risk of rejection of your transplanted organ.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
4. Possible adverse effects
Like all medicines, this medicine can cause adverse effects, although not everyone will experience them.
Some adverse effects may be serious
Tell your doctor immediately if you notice any of the following serious adverse effects:
- Like other medicines that act on the immune system, cyclosporine may affect your body's ability to fight certain infections and may cause tumors or other malignant diseases, especially of the skin. Signs of infection could include fever or sore throat.
- Vision disturbances, lack of coordination, clumsiness, memory loss, difficulty speaking or understanding others, and muscle weakness. These could be signs of a brain infection called progressive multifocal leukoencephalopathy.
- Brain problems with signs such as seizures, confusion, disorientation, reduced sensation, personality changes, agitation, insomnia, vision disturbances, blindness, coma, paralysis of part or all of the body, torticollis, lack of coordination with or without abnormal speech or eye movements.
- Inflammation at the back of the eye that may be associated with blurred vision. It may also affect your vision due to increased pressure inside the head (benign intracranial hypertension).
- Liver injury and abnormalities, with or without yellowing of the eyes or skin, nausea, vision loss, and dark urine.
- Kidney problems, which may greatly reduce the amount of urine you produce.
- Decrease in the number of red blood cells or platelets. These signs include pale skin, fatigue, shortness of breath, dark urine (a sign of red blood cell breakdown), unexplained bleeding or bruising, confusion, disorientation, difficulty concentrating, and kidney problems.
Other adverse effects include:
Very common: may affect more than 1 in 10 people
- Kidney problems.
- High blood pressure.
- Headache.
- Involuntary body tremors.
- Excessive growth of facial and body hair.
- Increased blood lipids.
If any of these affect you severely, tell your doctor.
Common: may affect up to 1 in 10 people
- Seizures.
- Liver problems.
- Increased blood sugar.
- Fatigue.
- Loss of appetite.
- Nausea (feeling of sickness), vomiting, stomach discomfort/pain, diarrhea.
- Excessive hair growth.
- Acne, hot flushes.
- Fever.
- Decrease in white blood cells.
- Numbness or tingling sensation.
- Muscle pain, muscle spasms.
- Stomach ulcer.
- Overgrowth of gum tissue, which may cover your teeth.
- Increased uric acid or potassium in the blood, decreased magnesium levels in the blood.
If any of these affect you severely, tell your doctor.
Uncommon: may affect up to 1 in 100 people
- Symptoms of brain disturbances including sudden seizures, mental confusion, insomnia, disorientation, vision changes, unconsciousness, feeling of weakness in the limbs, impaired movement.
- Skin rash.
- Generalized swelling.
- Weight gain.
- Decrease in red blood cells and platelets in the blood, which may increase the risk of bleeding.
If any of these affect you severely, tell your doctor.
Rare: may affect up to 1 in 1,000 people
- Nerve disturbances causing numbness or tingling in fingers and toes.
- Pancreatitis with severe upper stomach pain.
- Muscle weakness, loss of muscle strength, leg or hand muscle pain, or pain in any part of the body.
- Destruction of red blood cells, including kidney problems with symptoms such as swelling of the face, abdomen, hands and/or feet, reduced urine output, difficulty breathing, chest pain, seizures, unconsciousness.
- Changes in menstrual cycle, breast enlargement in men.
If any of these affect you severely, tell your doctor.
Very rare: may affect up to 1 in 10,000 people
- Inflammation at the back of the eye that may be associated with increased pressure inside the head and deterioration of vision.
If this affects you severely, tell your doctor.
Frequency not known: Cannot be estimated from available data.
- Severe liver problems with or without yellowing of the eyes or skin, nausea (feeling of sickness), loss of appetite, dark urine, swelling of the face, feet, hands and/or whole body.
- Bleeding under the skin or purple spots on the skin, sudden unexplained bleeding.
- Migraine or severe headache, often with dizziness or associated symptoms (nausea, vomiting), and sensitivity to light.
- Leg and foot pain.
- Hearing impairment.
If any of these affect you severely, tell your doctor.
If you experience any adverse effects, consult your doctor or pharmacist, even if they are adverse effects not listed in this leaflet.
Additional adverse effects in children and adolescents
No additional adverse effects are expected in children and adolescents compared to adults.
Reporting of adverse effects
If you experience any adverse effect, talk to your doctor or pharmacist, even if it is a possible adverse effect not listed in this leaflet. You can also report them directly via the Spanish Pharmacovigilance System for Human Medicines (www.notificaRAM.es). By reporting adverse effects, you can help provide more information on the safety of this medicine.
5. Storage of Sandimmun Neoral
- Keep this medicine out of the sight and reach of children.
- Do not use this medicine after the expiry date stated on the packaging.
- Do not store the capsules in a warm place. Do not store above 25°C.
- Store in the original packaging to protect from moisture.
- Keep the capsules in the blister pack. Remove them only at the time of taking your medicine.
- When the blister pack is opened, a characteristic odour may be noticed, which is completely normal and does not indicate that the capsule is defective.
- Medicines must not be disposed of via wastewater or household waste. Dispose of unused medicines and their containers at the SIGRE collection point at your pharmacy. If you are in doubt, ask your pharmacist how to properly dispose of unused medicines and their packaging. This will help protect the environment.
6. Contents of the pack and other information
Composition of Sandimmun Neoral
- The active substance is ciclosporin. Each capsule contains 25 mg of ciclosporin.
- The other components are:
- Capsule contents: alpha-tocopherol, anhydrous ethanol, propylene glycol, mono-di-triglycerides of corn oil, macrogol glycerol hydroxystearate / polyoxyl hydrogenated castor oil.
- Capsule shell: black iron oxide (E172), titanium dioxide (E171), 85% glycerol, propylene glycol, gelatin.
- Printing ink: carmine acid (E 120), aluminum chloride hexahydrate, sodium hydroxide, propylene glycol, hypromellose/hydroxypropylmethylcellulose 2910, isopropanol/isopropyl alcohol.
Appearance of Sandimmun Neoral and contents of the pack
Sandimmun Neoral 25 mg soft capsules are grey-blue, oval-shaped soft capsules, printed with “NVR 25mg” in red.
They are available in packs containing 5, 20, 30, 50, 60 and 90 soft capsules.
Only certain pack sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
Novartis Farmacéutica, S.A.
Gran Via de les Corts Catalanes, 764
08013 – Barcelona (Spain)
Telephone: +34 93 306 42 00
Manufacturer
179 Giannou Kranidioti 2235 Latsia, Nicosia Cyprus
12th km National Road Athens-Lamia 14451 Metamorphoses Greece
Avenida Professor Doutor Cavaco Silva n.º 10E Taguspark 2740-255 Porto Salvo Portugal
Via Provinciale Schito 131 80058 Torre Annunziata, NA Italy
Gran Via de les Corts Catalanes, 764 08013 Barcelona Spain
Bartók Béla út 43-47. 1114 Budapest Hungary
Verovskova Ullica, 57 Ljubljana, 1000 Slovenia |
Haaksbergweg 16 1101 BX Amsterdam Netherlands
Jakov-Lind-Straße 5, Top 3.05 1020 Wien Austria
8-10, rue Henri Sainte-Claire Deville 92500 Rueil-Malmaison France
Torshamnsgatan 48 164 40 Kista Sweden
Viale Luigi Sturzo, 43 20154-Milano (MI) Italy
Trimlini 2D 9220 Lendava Slovenia
Sophie-Germain-Strasse 10 90443 Nürnberg Germany |
This medicinal product is authorized in the Member States of the European Economic Area and in the United Kingdom (Northern Ireland) under the following names:
Germany | Sandimmun Optoral |
Austria, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Greece, Finland, Hungary, Iceland, Italy, Lithuania, Latvia, Malta, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Sweden, Spain | Sandimmun Neoral |
Belgium, Luxembourg | Neoral-Sandimmun |
Ireland, Netherlands, United Kingdom (Northern Ireland) | Neoral |
France | Néoral |
Date of the last review of this leaflet: 05/2023
Other sources of information
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/